Predictors and Outcomes of Ustekinumab Dose Intensification in Ulcerative Colitis: A Multicenter Cohort Study
Rahul S. Dalal, Scott Esckilsen, Edward L. Barnes, Jordan C. Pruce, Jenna Marcus, Jessica R. Allegretti
Topics & Concepts
UstekinumabMedicineUlcerative colitisVedolizumabCohortInternal medicineCohort studyDosingDiseaseInfliximabInflammatory Bowel DiseaseChronic Lymphocytic Leukemia ResearchImmunodeficiency and Autoimmune Disorders